Viewing Study NCT00189358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-01-24 @ 4:13 AM
Study NCT ID: NCT00189358
Status: COMPLETED
Last Update Posted: 2010-07-20
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy
Sponsor: AGO Study Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Cancer of the Fallopian Tube View
None Peritoneal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None cancer alternative therapies View
None ovarian cancer View
None tyrosine kinase inhibitor View